BJL
BMY icon

Brighton Jones LLC’s Bristol-Myers Squibb BMY Stock Holding History

Brighton Jones LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.46M Buy
139,568
+29,028
+26% +$1.69M 0.19% 69
2025
Q4 		$5.96M Buy
110,540
+76,067
+221% +$3.66M 0.22% 45
2025
Q3 		$1.55M Buy
34,473
+9,645
+39% +$450K 0.04% 273
2025
Q2 		$1.15M Buy
24,828
+2,997
+14% +$147K 0.03% 294
2025
Q1 		$1.33M Buy
21,831
+2,103
+11% +$123K 0.04% 221
2024
Q4 		$1.12M Buy
19,728
+4,935
+33% +$276K 0.03% 237
2024
Q3 		$765K Sell
14,793
-3,376
-19% -$158K 0.03% 252
2024
Q2 		$755K Sell
18,169
-947
-5% -$42.4K 0.02% 269
2024
Q1 		$1.04M Buy
19,116
+1,650
+9% +$84.1K 0.04% 219
2023
Q4 		$896K Sell
17,466
-8,408
-32% -$441K 0.04% 222
2023
Q3 		$1.5M Buy
25,874
+749
+3% +$45.9K 0.08% 148
2023
Q2 		$1.61M Buy
25,125
+1,638
+7% +$110K 0.08% 142
2023
Q1 		$1.63M Sell
23,487
-108
-0.5% -$7.62K 0.09% 134
2022
Q4 		$1.7M Sell
23,595
-3,314
-12% -$250K 0.1% 116
2022
Q3 		$1.91M Buy
26,909
+772
+3% +$56K 0.11% 100
2022
Q2 		$2.01M Buy
26,137
+345
+1% +$26.3K 0.12% 102
2022
Q1 		$1.88M Buy
25,792
+2,049
+9% +$138K 0.09% 112
2021
Q4 		$1.48M Buy
23,743
+2,041
+9% +$120K 0.07% 133
2021
Q3 		$1.28M Buy
21,702
+1,327
+7% +$87.4K 0.07% 130
2021
Q2 		$1.36M Sell
20,375
-486
-2% -$31.7K 0.07% 122
2021
Q1 		$1.32M Buy
20,861
+3,190
+18% +$198K 0.08% 118
2020
Q4 		$1.1M Sell
17,671
-1,818
-9% -$112K 0.07% 120
2020
Q3 		$1.18M Buy
19,489
+2,923
+18% +$176K 0.08% 103
2020
Q2 		$974K Buy
16,566
+3,352
+25% +$200K 0.08% 106
2020
Q1 		$737K Sell
13,214
-556
-4% -$34K 0.08% 119
2019
Q4 		$884K Buy
13,770
+3,769
+38% +$216K 0.1% 127
2019
Q3 		$507K Sell
10,001
-1,534
-13% -$72.1K 0.06% 167
2019
Q2 		$523K Sell
11,535
-360
-3% -$16.8K 0.06% 167
2019
Q1 		$567K Sell
11,895
-780
-6% -$38.9K 0.07% 155
2018
Q4 		$659K Buy
12,675
+1,107
+10% +$59.5K 0.1% 115
2018
Q3 		$718K Sell
11,568
-1,310
-10% -$77.7K 0.09% 120
2018
Q2 		$713K Buy
12,878
+1,429
+12% +$77.2K 0.09% 130
2018
Q1 		$724K Sell
11,449
-1,211
-10% -$77.9K 0.1% 115
2017
Q4 		$776K Sell
12,660
-2,455
-16% -$154K 0.09% 110
2017
Q3 		$963K Sell
15,115
-1,019
-6% -$59.5K 0.12% 93
2017
Q2 		$899K Buy
16,134
+2,538
+19% +$138K 0.13% 91
2017
Q1 		$739K Buy
13,596
+6,336
+87% +$348K 0.18% 44
2016
Q4 		$424K Sell
7,260
-5,738
-44% -$314K 0.16% 54
2016
Q3 		$701K Sell
12,998
-223
-2% -$14.3K 0.11% 98
2016
Q2 		$972K Sell
13,221
-138
-1% -$9.75K 0.17% 74
2016
Q1 		$853K Sell
13,359
-740
-5% -$46.7K 0.16% 80
2015
Q4 		$970K Buy
14,099
+572
+4% +$37.8K 0.19% 62
2015
Q3 		$801K Buy
13,527
+223
+2% +$14.1K 0.17% 68
2015
Q2 		$885K Buy
13,304
+25
+0.2% +$1.65K 0.2% 55
2015
Q1 		$857K Sell
13,279
-858
-6% -$53.7K 0.19% 56
2014
Q4 		$835K Sell
14,137
-1,272
-8% -$71.7K 0.19% 60
2014
Q3 		$789K Sell
15,409
-60
-0.4% -$3K 0.18% 67
2014
Q2 		$750K Sell
15,469
-175
-1% -$8.62K 0.17% 67
2014
Q1 		$813K Buy
15,644
+1,032
+7% +$54.9K 0.19% 58
2013
Q4 		$777K Buy
14,612
+1,931
+15% +$98.4K 0.18% 61
2013
Q3 		$587K Buy
12,681
+1,193
+10% +$52.4K 0.15% 67
2013
Q2 		$513K Buy
+11,488
New +$499K 0.15% 56

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brighton Jones LLC's BMY Position: Q1 2026 in Review

Brighton Jones LLC increased its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2026, buying an estimated $1.69M and bringing the position to 139,568 shares worth $8.46M. The position accounts for 0.19% of the portfolio, ranked #69.

Brighton Jones LLC first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Brighton Jones LLC held 139,568 shares of Bristol-Myers Squibb worth $8.46M as of Q1 2026.
  • Brighton Jones LLC bought 29,028 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.69M.
  • Bristol-Myers Squibb made up 0.19% of Brighton Jones LLC's portfolio in Q1 2026, its #69 holding.
  • Brighton Jones LLC first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.